HCW Biologics Inc.
SEC CIK 1828673 · HCWB · last insider filing 2026-05-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Garrett Scott T | Director | filed 2021 - 2026 |
| Wong Hing C | Director · Chief Executive Officer | filed 2021 - 2026 |
| Winer Gary M | Director | filed 2021 - 2025 |
| Greene Rick S. | Director | filed 2021 - 2025 |
| Giles Lisa M. | Director | filed 2021 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Byam Rebecca | Chief Financial Officer | filed 2021 - 2026 |
| Flowers Lee | SVP of Business Development | filed 2021 - 2025 |
| Rhode Peter | See Remarks | filed 2021 - 2023 |
| Jiao Jin-an | VP of Development | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.